Barclays PLC Pacira Bio Sciences, Inc. Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $32,093 - $40,491	-900 Reduced 90.0%	100 $4,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $18,285 - $23,985	500 Added 100.0%	1,000 $43,000
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $4.52 Million - $6.55 Million	-164,500 Reduced 99.7%	500 $16,000
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $4.19 Million - $6.48 Million	139,800 Added 554.76%	165,000 $5.14 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $2.63 Million - $3.88 Million	-82,700 Reduced 76.65%	25,200 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $3.85 Million - $4.26 Million	107,900	107,900 $4.05 Million

253

48.5M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.22B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.